Buy Cogint Stock | COGT Stock Price & Latest News | Public.com
COGT

Cogint

$0.00 (0.00%)Today
    Small Market Cap
    View Cogint (COGT) stock trends here

    About COGT

    Cogent Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient’s immune system to cure cancer. The firm’s technologies include Antibody-Co...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -1.69
    -3.38
    -5.07
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.28

    Actual EPS
    Q1 2021

    Stats

    Market Cap$507,11M
    Volume18,4k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$14.88
    1 Year Low$1.18
    Open$8.25
    High$8.29
    Low$7.82

    Buy any stock with any amount of money.

    Download the App
    Download the app